Herlev, Denmark

Peter Esben Friis

This inventor holds 1 USPTO granted patent. Top assignee: Novozymes A/s. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Esben Friis. Retrieved from https://idiyas.com/inventor/peter-esben-friis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Peter Esben Friis

Introduction

Peter Esben Friis is a notable inventor based in Herlev, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of protease variants. His work has implications for various applications in industry and research.

Latest Patents

Peter Esben Friis holds 1 patent for his invention titled "Protease variants and polynucleotides encoding same." This invention relates to protease variants and methods for obtaining these variants. It also encompasses polynucleotides encoding the variants, nucleic acid constructs, vectors, and host cells that include the polynucleotides. Furthermore, the invention outlines methods for utilizing these protease variants effectively.

Career Highlights

Peter is currently employed at Novozymes A/S, a leading company in the field of biotechnology. His role at Novozymes allows him to work on innovative solutions that enhance enzyme technology and its applications in various industries.

Collaborations

Throughout his career, Peter has collaborated with esteemed colleagues such as Annette Helle Johansen and Rolf Thomas Lenhard. These collaborations have contributed to the advancement of research and development in protease technology.

Conclusion

Peter Esben Friis is a distinguished inventor whose work in protease variants has the potential to impact multiple sectors. His contributions to Novozymes A/S and the broader scientific community highlight the importance of innovation in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…